Genevoyager

Wuhan, China · Founded 2022 · Privately Held (backing)

Developer of biopharmaceutical development and production systems designed for gene therapy and vaccine research purposes. Genevoyager is based in Wuhan, China and was founded in 2022. It has raised $27.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$27.9M
Last round
—
Valuation — not yet established

No valuation for Genevoyager is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($27.9M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genevoyager with a free account
  • ·Watch Genevoyager: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Genevoyager funding history

No rounds on record

No funding rounds for Genevoyager are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Genevoyager's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Genevoyager, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Genevoyager

How much has Genevoyager raised?
Genevoyager has raised $27.9M in total funding across its recorded rounds.